[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-10,14,17,17-tetramethyl-15-[(3S)-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxymethoxy)hexanoyl]oxy-11-oxo-9,12-bis(phenylmethoxycarbonyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | 849213-19-0

• 英文名称: [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-10,14,17,17-tetramethyl-15-[(3S)-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxymethoxy)hexanoyl]oxy-11-oxo-9,12-bis(phenylmethoxycarbonyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
• CAS: 849213-19-0
• 化学式: C₆₅H₇₇NO₁₉
• 分子量: 1176.32
• InChiKey: QFKULAFHUWNNRW-IOKOTNJUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  10
• 重原子数：
  85
• 可旋转键数：
  29
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.49
• 拓扑面积：
  253
• 氢给体数：
  2
• 氢受体数：
  19

反应信息

• 作为反应物：
  描述：

  [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-10,14,17,17-tetramethyl-15-[(3S)-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxymethoxy)hexanoyl]oxy-11-oxo-9,12-bis(phenylmethoxycarbonyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate 在 4-二甲氨基吡啶 、 palladium 10% on activated carbon 、 camphor-10-sulfonic acid 盐酸 、 甲醇 、 sodium tetrahydroborate 、 氢气 、 N-甲基吗啉氧化物 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 116.0h， 生成 [(1R,2S,3S,5S,8S,9R,10S,11S,13R,16S)-8,16-diacetyloxy-9,11-dihydroxy-5-[(3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.03,7.013,16]hexadec-6-en-2-yl] benzoate
  参考文献：
  名称：

  WO2008/121476

  摘要：

  公开号：
• 作为产物：
  描述：

  10-脱乙酰基巴卡丁 III 在 4-二甲氨基吡啶 、 正己基锂 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 7.5h， 生成 [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-10,14,17,17-tetramethyl-15-[(3S)-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxymethoxy)hexanoyl]oxy-11-oxo-9,12-bis(phenylmethoxycarbonyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
  参考文献：
  名称：

  [EN] 9,10-alpha,alpha-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF
  [FR] ANALOGUES DE 9,10-20050714US5635531ACHEN SHU-HUI [US]19970603XX

  摘要：

  公开号：

  WO2005030150A3

文献信息

• WO2008/106621
  申请人：——

  公开号：——

  公开（公告）日：——
• 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof
  申请人：ZYGMUNT Jan

  公开号：US20100324128A1

  公开（公告）日：2010-12-23

  The present invention relates to a method for the treatment of cancer in a cancer patient. In particular, the invention provides a method for the treatment comprising administering a taxane compound to a cancer patient, wherein the taxane compound is made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: with a second compound of generalized formula R 8 R 9 C(OCH 3 ) 2 and an acid selected from the group consisting of camphor sulfonic acid (CSA), p-toluene sulfonic acid (PTSA), hydrochloric acid (HCl) and acetic acid (AcOH), wherein R 1 and R 2 are each selected from H, an alkyl group, an olefinic group, an aromatic group, an O-alkyl group, an O-olefinic group, or an O-aromatic group; R 7 is an alkyl group, an olefinic group, or an aromatic group; P 1 is a hydroxyl protecting group; P 5 is H or an acid labile protecting group at the 7-O position; R 8 is H, alkyl group, olefinic or aromatic group; and R 9 is: H, alkyl group, olefinic or aromatic or is as defined in the specification.
• US7745650B2
  申请人：——

  公开号：US7745650B2

  公开（公告）日：2010-06-29